| Name | Title | Contact Details |
|---|
DNA2.0 is a privately-held, leading synthetic genomics company, headquartered in Menlo Park, CA.
NextHealth Technologies (NHT), based in Denver CO, drives measurable medical cost reduction through a prescriptive analytics and consumer engagement platform. NextHealth’s proprietary SaaS platform integrates three foundational technologies - prescriptive analytics, behavioral economics, and multichannel consumer engagement. This end-to end, technology-enabled solution predicts risk reduction opportunities and then prescribes personalized member level actions or “nudges" to dramatically improve outcomes. NHT has been able to deliver a sustained and ground breaking 25% reduction in ER visits and over $17 per member per year in medical claims cost reduction for targeted commercial, ASO, and Medicaid populations. NHT offers over 30+ use cases including ER visit reduction, out-of-network reduction, and retention of high value individual members. NextHealth offers an at risk managed services contract based on 20% of causal claims savings. These results have led the company to be named by Gartner as one of the most innovative healthcare analytics vendors in the US. NHT’s multi-year software and managed services solution is currently contracted and supporting over 1.5 million members with some of the most reputable health plans in the country including: UnitedHealthcare, BlueCross BlueShield of Tennessee, and Colorado Access.
Suncoast Communities Blood Bank is a Sarasota, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Centric Medical Communications, Inc. is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Clinical Reference Laboratory was founded in 1979 under the name Enzyme Technology. Enzyme Technology placed its emphasis on modifying and patenting immunoassay techniques used in toxicology, serology, and urinalysis.